TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 172 filers reported holding TRAVERE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $710 | -11.6% | 79,370 | +51.8% | 0.03% | -5.7% |
| Q2 2023 | $803 | -19.5% | 52,300 | +10.3% | 0.04% | -36.4% |
| Q4 2022 | $997 | -99.9% | 47,422 | -17.7% | 0.06% | -36.0% |
| Q3 2022 | $1,420,000 | +10.8% | 57,622 | +8.9% | 0.09% | -10.4% |
| Q2 2022 | $1,282,000 | +98.1% | 52,902 | +110.6% | 0.10% | +128.6% |
| Q1 2022 | $647,000 | – | 25,122 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MASSMUTUAL TRUST CO FSB/ADV | 235 | $2,113 | 0.00% |